CLINICAL_TRIALS
trial_result
· 2017-03-30
Clinical Trial Update: Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer [Phase 3]
Summary
A Phase 3 trial of Tecemotide (L-BLP25) in non-small cell lung cancer terminated after concurrent chemoradiotherapy; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: TERMINATED | Results posted: 2017-03-30